/ Strides Shasun Receives USFDA Nod For Promethazine Hydrochloride Tablets ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Monday, 3 July 2017

On Monday Strides Shasun announced that they have receivedapproval from USFDA for Promethazine Hydrochloride tablets, USP12.5 Mg, 25 mg and 50 mg.

The US market for Promethazine Hydrochloride tablets, USP 12.5 Mg, 25 mg and 50 mg is approximately USD 17 million as according to the IMS data. The product is marked by Strides Pharma Inc in the US market and the product is manufactured at the company flagship facility in Bangalore.

These tablets are used for prevent and treatment of nausea and vomiting related to the certain condition and treat allergy symptoms such as rash, itching and runny nose.

On Friday the Strides Shasun stocks ended on NSE at Rs 998/share lower Rs 2.55/share or 0.25% and has delivered negative returns of 11% and has underperformed the BSE Mid-Cap and BSE health careindices in a period of the one year.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.co
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔
Give a Missed Call for Free Trial - 09699997717 ✔